MGEA5.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
20 20
|Entity|Tier|Description |
21 21
|:------:|:----:|--------------------------------------|
22
-|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@hubschmannMutationalMechanismsShaping2021b]|
22
+|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@hubschmannMutationalMechanismsShaping2021]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
MIR142.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
|Entity|Tier|Description |
20 20
|:------:|:----:|-----------------------------------------|
21 21
|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established [@grandeGenomewideDiscoverySomatic2019]|
22
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@kwanhianMicroRNA142Mutated202012b]|
22
+|![DLBCL](images/icons/DLBCL_tier2.png) |2 |relevance in DLBCL not firmly established[@kwanhianMicroRNA142Mutated202012]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
MKI67.md
... ...
@@ -19,7 +19,7 @@ timeline
19 19
|Entity|Tier|Description |
20 20
|:------:|:----:|--------------------------------------|
21 21
|![BL](images/icons/BL_tier2.png) |2 |relevance in BL not firmly established[@schmitzBurkittLymphomaPathogenesis2012]|
22
-|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@russler-germainMutationsAssociatedProgression2023b]|
22
+|![FL](images/icons/FL_tier2.png) |2 |relevance in FL not firmly established[@russler-germainMutationsAssociatedProgression2023]|
23 23
24 24
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
25 25
MS4A1.md
... ...
@@ -24,7 +24,7 @@ timeline
24 24
25 25
|Entity|Tier|Description |
26 26
|:------:|:----:|--------------------------|
27
-|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@mottokIntegrativeGenomicAnalysis2019b]|
27
+|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@mottokIntegrativeGenomicAnalysis2019]|
28 28
|![DLBCL](images/icons/DLBCL_tier1.png) |1-a | aSHM target and high-confidence DLBCL gene[@rushtonGeneticEvolutionaryPatterns2020]|
29 29
30 30
## Mutation incidence in large patient cohorts (GAMBL reanalysis)